• SIPLIZUMAB chembl:CHEMBL2108742 Antineoplastic

    Alternate Names:

    SIPLIZUMAB
    MEDI-507

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • Interaction Score: 61.83

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction T-cell surface antigen CD2 inhibitor
    Direct Interaction yes
    Trial Name siplizumab, MEDI-507

    PMIDs:
    None found